Menu

Filtros : "FÁRMACOS" "2022" "Alemanha" Limpar

Filtros

Refine with date range

  • 1

1 - 3 (3 records)

  • Artigo de periodico

    Synthesis of Lobeglitazone intermediates seeking for continuous drug production in flow capillary microreactor (2022)

    Silva, Renan Rodrigues de Oliveira; Calvo, Paulo Victor Cuesta ; Merfels, Christian Adrian; Lima, Mikael Vitor Rodrigues ; Santana, Harrson S ; Converti, Attilio ; Palma, Mauri Sérgio Alves

    Source: Journal of Industrial and Engineering Chemistry. Unidade: FCF

    Subjects: FÁRMACOS, CINÉTICA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SILVA, Renan Rodrigues de Oliveira et al. Synthesis of Lobeglitazone intermediates seeking for continuous drug production in flow capillary microreactor. Journal of Industrial and Engineering Chemistry, v. 116, p. 239-249, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jiec.2022.09.014. Acesso em: 01 out. 2024.

    • APA

      Silva, R. R. de O., Calvo, P. V. C., Merfels, C. A., Lima, M. V. R., Santana, H. S., Converti, A., & Palma, M. S. A. (2022). Synthesis of Lobeglitazone intermediates seeking for continuous drug production in flow capillary microreactor. Journal of Industrial and Engineering Chemistry, 116, 239-249. doi:10.1016/j.jiec.2022.09.014

    • NLM

      Silva RR de O, Calvo PVC, Merfels CA, Lima MVR, Santana HS, Converti A, Palma MSA. Synthesis of Lobeglitazone intermediates seeking for continuous drug production in flow capillary microreactor [Internet]. Journal of Industrial and Engineering Chemistry. 2022 ; 116 239-249.[citado 2024 out. 01 ] Available from: https://doi.org/10.1016/j.jiec.2022.09.014

    • Vancouver

      Silva RR de O, Calvo PVC, Merfels CA, Lima MVR, Santana HS, Converti A, Palma MSA. Synthesis of Lobeglitazone intermediates seeking for continuous drug production in flow capillary microreactor [Internet]. Journal of Industrial and Engineering Chemistry. 2022 ; 116 239-249.[citado 2024 out. 01 ] Available from: https://doi.org/10.1016/j.jiec.2022.09.014

  • Artigo de periodico

    D2-like receptor activation by intranasal dopamine attenuates fear responses induced by electrical stimulation of the dorsal periaqueductal grey matter, but fails to reduce aversion to pit vipers and T-maze performance (2022)

    Figueiredo, Rebeca Machado de; Falconi-Sobrinho, Luiz Luciano ; Leite-Panissi, Christie Ramos Andrade ; Huston, Joseph P.; Mattern, Claudia; Carvalho, Milene Cristina de ; Coimbra, Norberto Cysne

    Source: Journal of Psychopharmacology. Unidades: FFCLRP, FMRP

    Subjects: FÁRMACOS, MEDO, NARIZ (SISTEMA RESPIRATÓRIO)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FIGUEIREDO, Rebeca Machado de et al. D2-like receptor activation by intranasal dopamine attenuates fear responses induced by electrical stimulation of the dorsal periaqueductal grey matter, but fails to reduce aversion to pit vipers and T-maze performance. Journal of Psychopharmacology, v. 36, n. 11, p. 1257-1272, 2022Tradução . . Disponível em: https://doi.org/10.1177/02698811221128018. Acesso em: 01 out. 2024.

    • APA

      Figueiredo, R. M. de, Falconi-Sobrinho, L. L., Leite-Panissi, C. R. A., Huston, J. P., Mattern, C., Carvalho, M. C. de, & Coimbra, N. C. (2022). D2-like receptor activation by intranasal dopamine attenuates fear responses induced by electrical stimulation of the dorsal periaqueductal grey matter, but fails to reduce aversion to pit vipers and T-maze performance. Journal of Psychopharmacology, 36( 11), 1257-1272. doi:10.1177/02698811221128018

    • NLM

      Figueiredo RM de, Falconi-Sobrinho LL, Leite-Panissi CRA, Huston JP, Mattern C, Carvalho MC de, Coimbra NC. D2-like receptor activation by intranasal dopamine attenuates fear responses induced by electrical stimulation of the dorsal periaqueductal grey matter, but fails to reduce aversion to pit vipers and T-maze performance [Internet]. Journal of Psychopharmacology. 2022 ; 36( 11): 1257-1272.[citado 2024 out. 01 ] Available from: https://doi.org/10.1177/02698811221128018

    • Vancouver

      Figueiredo RM de, Falconi-Sobrinho LL, Leite-Panissi CRA, Huston JP, Mattern C, Carvalho MC de, Coimbra NC. D2-like receptor activation by intranasal dopamine attenuates fear responses induced by electrical stimulation of the dorsal periaqueductal grey matter, but fails to reduce aversion to pit vipers and T-maze performance [Internet]. Journal of Psychopharmacology. 2022 ; 36( 11): 1257-1272.[citado 2024 out. 01 ] Available from: https://doi.org/10.1177/02698811221128018

  • Artigo de periodico

    Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial (2022)

    Butler, Javed ; Anker, Stefan D ; Lund, Lars H. ; Coats, Andrew J. S.; Filippatos, Gerasimos ; Siddiqi, Tariq Jamal; FRIEDE, Tim ; Fabien, Vincent ; Kosiborod, Mikhail; Metra, Marco

    Source: European heart journal. Unidade: FM

    Subjects: PLACEBOS, POTÁSSIO, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BUTLER, Javed et al. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. European heart journal, v. 43, n. 41, p. 4362-4373, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50465. Acesso em: 01 out. 2024.

    • APA

      Butler, J., Anker, S. D., Lund, L. H., Coats, A. J. S., Filippatos, G., Siddiqi, T. J., et al. (2022). Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. European heart journal, 43( 41), 4362-4373. doi:10.1093/eurheartj/ehac401

    • NLM

      Butler J, Anker SD, Lund LH, Coats AJS, Filippatos G, Siddiqi TJ, FRIEDE T, Fabien V, Kosiborod M, Metra M. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial [Internet]. European heart journal. 2022 ; 43( 41): 4362-4373.[citado 2024 out. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50465

    • Vancouver

      Butler J, Anker SD, Lund LH, Coats AJS, Filippatos G, Siddiqi TJ, FRIEDE T, Fabien V, Kosiborod M, Metra M. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial [Internet]. European heart journal. 2022 ; 43( 41): 4362-4373.[citado 2024 out. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50465
  • 1

1 - 3 (3 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024